# Dexmedetomidine for Analgosedation to Newborn Infants During Neonatal Intensive Care

> **NCT06482775** · — · WITHDRAWN · sponsor: **Region Skane**

## Conditions studied

- Intensive Care, Neonatal
- Analgesia
- Hypnotics and Sedatives

## Interventions

- **DRUG:** dexmedetomidine

## Key facts

- **NCT ID:** NCT06482775
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Problems with the study costs after Covid-19
- **Last updated:** 2024-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482775, "Dexmedetomidine for Analgosedation to Newborn Infants During Neonatal Intensive Care". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06482775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*